Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells via MRGPRX2 and MrgprB2 is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01-AI124182, R01-AI143185, R01-AI149487
NIAID NIH HHS
Grant: R01 AI124182
NIAID NIH HHS
Grant: R01 AI143185
NIAID NIH HHS
Grant: R01 AI149487
National Institutes of Health
Grant: 5R01AI149487-03
Roles of novel MRGPRX2/MrgprB2 signaling in mast cells on host defense and Inflammation
National Institutes of Health
Grant: 5R01AI143185-03
Novel Roles of GRK2 and beta-arrestin2 on mast cell-mediated allergy and Inflammation
National Institutes of Health
Grant: 1R01AI124182-01A1
Role of a novel human mast cell G protein coupled receptor in Allergy and Inflammation
FWCI
1.17
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals